Effects of weekly bevacizumab and gemcitabine/oxaliplatin with or without dasatinib on heavily pretreated patients with recurrent or persistent cervical cancer.

e15579 Background: Prognoses of patients with recurrent and metastatic cervical cancer who received treatment including radiotherapy are commonly dismal. In such clinical settings effective treatme...